Pet medicine report lookup / Grapiprant / Dogs

What has been reported to the FDA for Grapiprant in dogs?

Short answer: The FDA has received 7,776 adverse event reports for dogs that name Grapiprant. The FDA lists 1 approved animal drug application containing Grapiprant for dogs, the earliest approved in 2016. These are counts of reports, not a rate of side effects.
Report counts read · approval records read
Veterinary disclosure Not veterinary advice. A report to the FDA is a suspicion, not proof that a medicine caused an event, and nothing here measures how often a side effect happens. Do not start, stop or change a medicine because of this page. Talk to a licensed veterinarian who knows your animal.
Grapiprantin dogs
7,776reports to the FDA

The FDA has received 7,776 adverse event reports for dogs that name Grapiprant.

  1. 7,776 reports name Grapiprant in dogs, which is 0.8% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
  2. 30% are marked serious and 10.0% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
  3. 17% are complaints that the product did not work (38% across all dog reports).
  4. The clinical signs reported most are vomiting, diarrhoea and lack of efficacy.
  5. The FDA lists 1 approved animal drug application containing Grapiprant for dogs, the earliest approved in 2016.
  6. None of this is a rate. The FDA data does not record how many dogs were given Grapiprant, so it cannot say how often any of this happens.

How the reports break down

What the reports sayReportsShare of this medicine's reportsAll dog reports
Marked seriousthe FDA record flags the report as serious2,36730%29%
Death or euthanasiathe outcome recorded in the report, with no finding of cause77510.0%5.4%
Did not worka complaint that the product failed to work, which the FDA files as an adverse event1,29017%38%
Seizurea seizure or convulsion is among the clinical signs3013.9%4.4%
Not used per labelthe report says the product was not used the way its label directs2,56333%21%

Where on the body do the reported signs sit?

45%20%4.4%

Not on the body: Whole body 16% Did not work 8.8%

  1. Stomach and gut45%vomiting, diarrhoea, not eating, decreased appetite and 4 more
  2. Blood and organ tests20%elevated alanine aminotransferase (alt), elevated blood urea nitrogen (bun), elevated serum alkaline phosphatase (sap), elevated creatinine and 3 more
  3. Whole body16%lethargy, death by euthanasia, lethargy, death
  4. Did not work8.8%lack of efficacy
  5. Brain and nerves4.4%seizure, ataxia
  6. Heart and breathing2.7%panting
  7. Behaviour2.5%behavioural disorder
  8. Thirst and urination1.7%polydipsia

Each figure is a share of sign mentions among the 25 signs reported most for Grapiprant in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.

Clinical signs reported most

  1. Vomiting1,468 19%
  2. Diarrhoea1,302 17%
  3. Lack of efficacy978 13%
  4. Lethargy658 8.5%
  5. Elevated alanine aminotransferase (ALT)521 6.7%
  6. Death by euthanasia492 6.3%
  7. Not eating490 6.3%
  8. Decreased appetite443 5.7%

Reports received per year

1,24102013: 1 reports2014: 0 reports2015: 1 reports2016: 0 reports2017: 1,241 reports2018: 1,197 reports2019: 968 reports2020: 791 reports2021: 547 reports2022: 549 reports2023: 544 reports2024: 732 reports2025: 811 reports2026: 394 reports2014201620182020202220242026first approved for dogs
More reports in a year can mean more animals treated, a newer product under closer watch, or more people reporting. 2026 is a part year. The tallest bar is 1,241 reports (2017). The earliest FDA approval for dogs was in 2016.

Is it approved for dogs?

DogsFDA-approved product listed
Catsno approved product found
Other animalsnone found
FDA-approved for dogs

The FDA lists 1 approved animal drug application containing Grapiprant for dogs, the earliest approved in 2016.

ProductFormApproved forFirst approvedFDA application
GalliprantElanco US Inc.Tablet RXDog2016141-455

From the FDA record for Galliprant: For oral use in dogs only.

What can you do next?

Seen a side effect yourself?Report itCall your veterinarian first if your animal is unwell. Then report to the drug maker or to the FDA: the FDA explains both routes. Reports like yours are what this page counts.

Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.

Where can you go from this result?

This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.

To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.

Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.

☆ Save